Trial Profile
A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Amlodipine/candesartan-cilexetil (Primary) ; Candesartan cilexetil
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Chong Kun Dang
- 23 Aug 2020 Status changed from recruiting to completed.
- 05 Feb 2016 New trial record